Home
/
Axsome Therapeutics, Inc.
/
Financials
/
Quarterly
Axsome Therapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Axsome Therapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2023
Jun 30, 2023
$31.30M
Aug 7, 2023
Q3
2022
Sep 30, 2021
$0
Nov 7, 2022
Q2
2022
Jun 30, 2021
$0
Aug 9, 2022
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$170.99M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$150.04M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$121.46M
May 5, 2025
Q3
2025
Sep 30, 2024
$104.76M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$87.17M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$75.00M
May 5, 2025
Q3
2024
Sep 30, 2023
$57.79M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$46.70M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$94.58M
May 6, 2024
Q3
2023
Sep 30, 2022
$16.85M
Nov 6, 2023
Q2
2023
Jun 30, 2022
$8.82M
Aug 7, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($47.23M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($47.97M)
Aug 4, 2025
Q3
2025
Jun 30, 2025
($47.97M)
Nov 3, 2025
Q2
2025
Mar 31, 2025
($59.41M)
Aug 4, 2025
Q3
2025
Mar 31, 2025
($59.41M)
Nov 3, 2025
Q1
2025
Mar 31, 2025
($59.41M)
May 5, 2025
Q3
2025
Sep 30, 2024
($64.60M)
Nov 3, 2025
Q3
2025
Jun 30, 2024
($79.35M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($79.35M)
Aug 4, 2025
Q3
2025
Mar 31, 2024
($68.36M)
Nov 3, 2025
Q1
2025
Mar 31, 2024
($68.36M)
May 5, 2025
Q2
2025
Mar 31, 2024
($68.36M)
Aug 4, 2025
Q3
2024
Sep 30, 2023
($62.20M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($67.17M)
Aug 5, 2024
Q3
2024
Jun 30, 2023
($67.17M)
Nov 12, 2024
Q1
2024
Mar 31, 2023
($11.22M)
May 6, 2024
Q2
2024
Mar 31, 2023
($11.22M)
Aug 5, 2024
Q3
2024
Mar 31, 2023
($11.22M)
Nov 12, 2024
Q3
2023
Sep 30, 2022
($44.82M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($41.44M)
Aug 7, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($46.11M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($36.71M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($56.98M)
May 5, 2025
Q3
2025
Sep 30, 2024
($62.62M)
Nov 3, 2025
Q2
2025
Jun 30, 2024
($78.05M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
($67.28M)
May 5, 2025
Q3
2024
Sep 30, 2023
($62.12M)
Nov 12, 2024
Q2
2024
Jun 30, 2023
($65.06M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($6.37M)
May 6, 2024
Q3
2023
Sep 30, 2022
($42.41M)
Nov 6, 2023
Q2
2023
Jun 30, 2022
($39.18M)
Aug 7, 2023
Q1
2023
Mar 31, 2022
($38.29M)
May 9, 2023
Q3
2022
Sep 30, 2021
($33.41M)
Nov 7, 2022
Q2
2022
Jun 30, 2021
($30.85M)
Aug 9, 2022
Q1
2022
Mar 31, 2021
($27.84M)
May 2, 2022
Q3
2021
Sep 30, 2020
($21.13M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($17.78M)
Aug 9, 2021
Q1
2021
Mar 31, 2020
($32.49M)
May 10, 2021
Q3
2020
Sep 30, 2019
($18.95M)
Nov 5, 2020
Q2
2020
Jun 30, 2019
($13.45M)
Aug 10, 2020